Literature DB >> 27485720

Factors for successful implementation of population-based expanded carrier screening: learning from existing initiatives.

Kim C A Holtkamp1, Inge B Mathijssen2, Phillis Lakeman2, Merel C van Maarle2, Wybo J Dondorp3, Lidewij Henneman1, Martina C Cornel1.   

Abstract

Background: Carrier screening for autosomal recessive disorders aims to facilitate reproductive decision-making by identifying couples with a 1-in-4 risk in every pregnancy of having an affected child. Except for a few countries or regions, carrier screening is not widely offered and is mostly ancestry-based. Technological advances enable carrier screening for multiple diseases simultaneously allowing universal screening regardless of ancestry (population-based expanded carrier screening). It is important to study how this can be successfully implemented. This study therefore aims to identify critical factors involved in successful implementation, from a user perspective, by learning from already implemented initiatives.
Methods: Factors associated with successful implementation were identified by: (i) a literature review and (ii) two case studies; studying experiences with carrier screening in two high-risk communities (a Dutch founder population and the Ashkenazi Jewish population), including a survey among community members.
Results: Factors identified were familiarity with (specific) genetic diseases and its availability, high perceived benefits of screening (e.g. screening avoids much suffering), acceptance of reproductive options, perceived risk of being a carrier and low perceived social barriers (e.g. stigmatization). In contrast to the Jewish community, the initial demand for screening in the Dutch founder population did not entirely come from the community itself. However, the large social cohesion of the community facilitated the implementation process.
Conclusion: To ensure successful implementation of population-based expanded carrier screening, efforts should be made to increase knowledge about genetic diseases, create awareness and address personal benefits of screening in a non-directive way.
© The Author 2016. Published by Oxford University Press on behalf of the European Public Health Association.

Entities:  

Mesh:

Year:  2017        PMID: 27485720      PMCID: PMC5421354          DOI: 10.1093/eurpub/ckw110

Source DB:  PubMed          Journal:  Eur J Public Health        ISSN: 1101-1262            Impact factor:   3.367


  38 in total

1.  The influence of experiential knowledge on prenatal screening and testing decisions.

Authors:  Holly Etchegary; Beth Potter; Heather Howley; Mario Cappelli; Doug Coyle; Ian Graham; Mark Walker; Brenda Wilson
Journal:  Genet Test       Date:  2008-03

Review 2.  ACOG Committee Opinion No. 486: Update on carrier screening for cystic fibrosis.

Authors: 
Journal:  Obstet Gynecol       Date:  2011-04       Impact factor: 7.661

3.  Attitudes of health care professionals toward carrier screening for cystic fibrosis. A review of the literature.

Authors:  S Janssens; A De Paepe; P Borry
Journal:  J Community Genet       Date:  2012-12-29

4.  "It's something I need to consider": decisions about carrier screening for fragile X syndrome in a population of non-pregnant women.

Authors:  Alison D Archibald; Alice M Jaques; Samantha Wake; Veronica R Collins; Jonathan Cohen; Sylvia A Metcalfe
Journal:  Am J Med Genet A       Date:  2009-12       Impact factor: 2.802

5.  Public experiences, knowledge and expectations about medical genetics and the use of genetic information.

Authors:  Lidewij Henneman; Danielle R M Timmermans; Gerrit van der Wal
Journal:  Community Genet       Date:  2004

Review 6.  Fear, anxiety, worry, and breast cancer screening behavior: a critical review.

Authors:  Nathan S Consedine; Carol Magai; Yulia S Krivoshekova; Lynn Ryzewicz; Alfred I Neugut
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-04       Impact factor: 4.254

7.  Examining the family-centred approach to genetic testing and counselling among UK Pakistanis: a community perspective.

Authors:  A Darr; N Small; W I U Ahmad; K Atkin; P Corry; J Benson; R Morton; B Modell
Journal:  J Community Genet       Date:  2012-10-21

8.  Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.

Authors:  Wybo Dondorp; Guido de Wert; Yvonne Bombard; Diana W Bianchi; Carsten Bergmann; Pascal Borry; Lyn S Chitty; Florence Fellmann; Francesca Forzano; Alison Hall; Lidewij Henneman; Heidi C Howard; Anneke Lucassen; Kelly Ormond; Borut Peterlin; Dragica Radojkovic; Wolf Rogowski; Maria Soller; Aad Tibben; Lisbeth Tranebjærg; Carla G van El; Martina C Cornel
Journal:  Eur J Hum Genet       Date:  2015-03-18       Impact factor: 4.246

9.  Population-based carrier screening for cystic fibrosis: a systematic review of 23 years of research.

Authors:  Liane Ioannou; Belinda J McClaren; John Massie; Sharon Lewis; Sylvia A Metcalfe; Laura Forrest; Martin B Delatycki
Journal:  Genet Med       Date:  2013-09-12       Impact factor: 8.822

10.  Knowledge and attitudes toward a free education and Ashkenazi Jewish carrier testing program.

Authors:  G Hegwer; C Fairley; J Charrow; K E Ormond
Journal:  J Genet Couns       Date:  2006-02       Impact factor: 2.717

View more
  16 in total

1.  Expanded genetic carrier screening in clinical practice: a current survey of patient impressions and attitudes.

Authors:  Nigel Pereira; Michelle Wood; Emerly Luong; Allison Briggs; Michael Galloway; Rose A Maxwell; Steven R Lindheim
Journal:  J Assist Reprod Genet       Date:  2019-02-13       Impact factor: 3.412

2.  Expanded carrier screening: what determines intended participation and can this be influenced by message framing and narrative information?

Authors:  Jan S Voorwinden; Anne H Buitenhuis; Erwin Birnie; Anneke M Lucassen; Marian A Verkerk; Irene M van Langen; Mirjam Plantinga; Adelita V Ranchor
Journal:  Eur J Hum Genet       Date:  2017-05-03       Impact factor: 4.246

3.  Preconception carrier screening for multiple disorders: evaluation of a screening offer in a Dutch founder population.

Authors:  Inge B Mathijssen; Kim C A Holtkamp; Cecile P E Ottenheim; Janneke M C van Eeten-Nijman; Phillis Lakeman; Hanne Meijers-Heijboer; Merel C van Maarle; Lidewij Henneman
Journal:  Eur J Hum Genet       Date:  2018-01-10       Impact factor: 4.246

Review 4.  Societal implications of expanded universal carrier screening: a scoping review.

Authors:  Lieke M van den Heuvel; Nina van den Berg; A Cecile J W Janssens; Erwin Birnie; Lidewij Henneman; Wybo J Dondorp; Mirjam Plantinga; Irene M van Langen
Journal:  Eur J Hum Genet       Date:  2022-09-12       Impact factor: 5.351

5.  Dynamics of reproductive genetic technologies: Perspectives of professional stakeholders.

Authors:  Ivy van Dijke; Carla G van El; Phillis Lakeman; Mariëtte Goddijn; Tessel Rigter; Martina C Cornel; Lidewij Henneman
Journal:  PLoS One       Date:  2022-06-21       Impact factor: 3.752

Review 6.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

7.  Direct to consumer genetic testing in Denmark-public knowledge, use, and attitudes.

Authors:  Anne-Marie Gerdes; Line Nicolaisen; Egil Husum; Janne Bayer Andersen; Martin Dræbye Gantzhorn; Laura Roos; Birgitte Rode Diness
Journal:  Eur J Hum Genet       Date:  2021-03-01       Impact factor: 5.351

8.  Outcomes of an International Workshop on Preconception Expanded Carrier Screening: Some Considerations for Governments.

Authors:  Caron M Molster; Karla Lister; Selina Metternick-Jones; Gareth Baynam; Angus John Clarke; Volker Straub; Hugh J S Dawkins; Nigel Laing
Journal:  Front Public Health       Date:  2017-02-24

9.  Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape.

Authors:  Kim C A Holtkamp; Evelien M Vos; Tessel Rigter; Phillis Lakeman; Lidewij Henneman; Martina C Cornel
Journal:  BMC Health Serv Res       Date:  2017-02-16       Impact factor: 2.655

Review 10.  Recent developments in genetics and medically assisted reproduction: from research to clinical applications.

Authors:  J C Harper; K Aittomäki; P Borry; M C Cornel; G de Wert; W Dondorp; J Geraedts; L Gianaroli; K Ketterson; I Liebaers; K Lundin; H Mertes; M Morris; G Pennings; K Sermon; C Spits; S Soini; A P A van Montfoort; A Veiga; J R Vermeesch; S Viville; M Macek
Journal:  Eur J Hum Genet       Date:  2017-12-04       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.